Skip to main content
PolicySpeak
← All files
AME

Affordable Medicines Europe

Industry association · Belgium · EU Transparency Register 509882515669-01

1
position filed
in the 326 files tracked
1
legislative file
of 326 tracked
0
with a full position paper
attached to a submission

Counts here are a floor, never a total: they cover the 326 consultation files tracked so far (29,503 submissions, mostly 2025–26), so an organization's real filing history is larger, not smaller.

Who they are

Among the 1205 trade and business associations on this site, they rank #832 by legislative files engaged — a count of participation, not a measure of influence.

3
declared lobbying FTE
self-declared
€500K+
declared costs / yr (floor)
3
EP accreditations
as declared to the register
2015
in the register since

Declares membership of

  • Affordable Medicines Europe is a member of:
  • the European Medicines Verification Organisation (EMVO)
  • the Alliance for Safe Online Pharmacy (ASOP EU)
  • the Federation of European and International Associations (FAIB)
  • Friends of Europe
  • European Society of Association Executives (ESAE)

Self-declared to the EU Transparency Register (snapshot 30 Aug 2026).

Register category
Trade and business associations
Head office
Brussels, Belgium

Self-declared to the EU Transparency Register (snapshot 30 Aug 2026); cost bands are floors, not audited totals. Reused under Commission Decision 2011/833/EU.

Track Affordable in PolicySpeak: request access →

Work at Affordable Medicines Europe? so we know who speaks for it.

Follow the file Affordable Medicines Europe engages with

One email on Tuesdays when a new position is filed on this file, from Affordable Medicines Europe or from anyone else on it. Only when there is something new.

We use your email for these updates, and PolicySpeak may contact you about the product. Unsubscribe in one click. Privacy policy.

Their record over time

Affordable Medicines Europe filed 1 position on 29 May 2026, across 1 of the 326 legislative files tracked here.

What they argued

Simplifying and reducing the burden of the rules on medical devices and in vitro diagnostic medical devices, and support of the European Medicines Agency for the expert panels on medical devices and the list of Union harmonisation legislationfiled 29 May 2026source

The Single Market plays an important role in supporting access to affordable medical devices across the EU. By enabling their redistribution between Member States, from markets where there is a surplus to others where there is a need, it contributes to improved availability, a more efficient allocation of medical devices, and greater affordability through enhanced competition.

Looking for an argument rather than an organization? Search every submission for a phrase and see everyone who used it.

Is this your organization?

Everything on this page comes from Affordable Medicines Europe’s own submissions to the European Commission — we have added nothing and interpreted nothing. If something is wrong or out of date, email info@policyspeak.com and we will correct it. If you are an individual named in a record, our privacy policy sets out your rights to correction, objection and removal.

Quotes are verbatim from submissions published by the European Commission, trimmed to their opening passage and never summarized by a model. Organizations only, never individuals. Reused under Commission Decision 2011/833/EU; the European Commission is not liable for this reuse.